Maravai LifeSciences logo

Maravai LifeSciences

MRVI | NASDAQ
Chart Builder DCF Calculator
$7.40
-$0.14 (-1.86%)
At close: Nov 16, 2026, 4:00 PM ET
$7.40
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.86%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
40.6
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #509/1021 (Top 50%)

Key Statistics

Market Data

Market Cap $2.1B
1D Range
7.09 7.60
52W Range
2.83 9.00

Valuation (TTM)

PE -16.44
PB 10.73
EV/EBITDA -55.08

Valuation (NTM)

Forward PE N/A
Forward PEG 0.22
Price Target $9.50
Loading financial charts...

Profile

Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and...

Sector Healthcare
Industry Biotechnology
Employees 415
IPO Date Nov 20, 2020
Fiscal Year January - December

Latest News

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2026 Earnings Call Transcript

10 days ago · seekingalpha.com

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2026 Earnings Call Transcript
What Maravai LifeSciences (MRVI) Said on Its Q3 Earnings Call

12 days ago · marketbeat.com

What Maravai LifeSciences (MRVI) Said on Its Q3 Earnings Call
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Beats Revenue Estimates

12 days ago · zacks.com

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Beats Revenue Estimates
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026

1 month ago · businesswire.com

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026
Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel

3 months ago · seekingalpha.com

Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates

3 months ago · zacks.com

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
Maravai LifeSciences Reports Second Quarter 2026 Financial Results

3 months ago · businesswire.com

Maravai LifeSciences Reports Second Quarter 2026 Financial Results
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026

4 months ago · businesswire.com

Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032

6 months ago · businesswire.com

Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.03
Beat +46.72%
REV
$45.85M
Beat +5.26%
Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$9.50
Upside
+28.38%
Buy (2)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.